Serum Biomarkers IL-6 and HIF-1α in Rosacea: Assessing Their Significance in Disease Pathogenesis and Telangiectasia...

Rosacea, a chronic inflammatory disease primarily affecting the central area of the face, is a complex condition whose mechanisms are still not fully understood. However, research has indicated a positive correlation between two molecules: hypoxia-inducible factor-1α (HIF-1α) and interleukin-6 (IL-6). The levels of HIF-1α in rosacea patients have yet to be assessed.

The aim of this study was to assess the levels of HIF-1α and IL-6 in patients with rosacea in relation to both the severity of the disease and the primary and secondary clinical manifestations of the condition.

The study included patients diagnosed with rosacea and sex-and age-matched healthy controls (N=40, N=40). Serum HIF-1α and IL-6 levels were quantified using enzyme-linked immunosorbent assay (ELISA).

Compared to the control group, the patient group had significantly elevated serum levels of HIF-1α and IL-6. A positive correlation was found between the level of HIF-1α and the severity of the disease (r=0.374, P=0.017); furthermore, a significant association was observed between the presence of telangiectasia, one of the primary manifestations, and HIF-1α (z=2.401, P=0.016).

The significantly elevated levels of IL-6 and HIF-1α in patients with rosacea compared to the control group support the hypothesis that these molecules play a role in the pathogenesis of the disease. The correlation between HIF-1α and the severity of the disease, and its significant elevation in patients with telangiectasia, suggest its potential involvement in the pathogenesis of the disease, particularly in the formation of telangiectasia.